Cure My Disease

Don't miss your cure!

Home News Browse About
Log in / Sign up
← Back to home

ALPORT SYNDROME

Clinical trials for ALPORT SYNDROME explained in plain language.

Never miss a new study

Get alerted when new ALPORT SYNDROME trials appear

Sign up with your email to follow new studies for ALPORT SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 7 Not yet recruiting 1 Not yet finished but already full! 1 Completed 7 Terminated 1
Sort by
  • New drug aims to slow kidney damage in rare alport syndrome

    Disease control Not yet recruiting

    This study tests a drug called exaluren in 24 people aged 12 and older with Alport syndrome caused by specific genetic errors. The drug is given as a daily shot for 32 weeks. Half the group starts exaluren right away, while the other half gets a placebo first and then switches to…

    Matched conditions: ALPORT SYNDROME

    Phase: PHASE2 • Sponsor: Eloxx Pharmaceuticals, Inc. • Aim: Disease control

    Last updated Jul 01, 2026 23:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space